Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly developed to help restore the massive health and economic disruption caused by the coronavirus disease 2019 (COVID-19) pandemic. By single-cell sorting 4,277 SARS-CoV-2 spike protein-specific memory B cells f...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreano, Emanuele, Nicastri, Emanuele, Paciello, Ida, Pileri, Piero, Manganaro, Noemi, Piccini, Giulia, Manenti, Alessandro, Pantano, Elisa, Kabanova, Anna, Troisi, Marco, Vacca, Fabiola, Cardamone, Dario, De Santi, Concetta, Torres, Jonathan L., Ozorowski, Gabriel, Benincasa, Linda, Jang, Hyesun, Di Genova, Cecilia, Depau, Lorenzo, Brunetti, Jlenia, Agrati, Chiara, Capobianchi, Maria Rosaria, Castilletti, Concetta, Emiliozzi, Arianna, Fabbiani, Massimiliano, Montagnani, Francesca, Bracci, Luisa, Sautto, Giuseppe, Ross, Ted M., Montomoli, Emanuele, Temperton, Nigel, Ward, Andrew B., Sala, Claudia, Ippolito, Giuseppe, Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901298/
https://www.ncbi.nlm.nih.gov/pubmed/33667349
http://dx.doi.org/10.1016/j.cell.2021.02.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901298/
https://www.ncbi.nlm.nih.gov/pubmed/33667349
http://dx.doi.org/10.1016/j.cell.2021.02.035

Ejemplares similares